Using mass spectrometry to validate mouse models of tauopathy
Using mass spectrometry to validate mouse models of tauopathy
About this item
Full title
Using mass spectrometry to validate mouse models of tauopathy
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Molecular neurodegeneration, 2023-04, Vol.18 (1), p.22-22, Article 22
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Keywords: Tau, Alzheimer's disease, Frontotemporal dementia, Phosphorylation, Mouse model, Tauopathy, Mass spectrometry
Alternative Titles
Full title
Using mass spectrometry to validate mouse models of tauopathy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6568806b8ab94574a62cf8b1a46e6f06
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6568806b8ab94574a62cf8b1a46e6f06
Other Identifiers
ISSN
1750-1326
E-ISSN
1750-1326
DOI
10.1186/s13024-023-00615-6
